Scotland’s Northern and Western Isles have long been known for their unique genetic makeup, shaped by centuries of historical isolation and limited migration. This genetic distinctiveness presents a valuable opportunity for researchers to identify rare genetic variants linked to an increased risk of certain diseases. More importantly, these genetic insights pave the way for personalised treatments, a growing priority in modern healthcare.
To address this need, the Viking Genes team at the University of Edinburgh launched a groundbreaking initiative aimed at improving diagnosis and enabling preemptive clinical intervention. Since its inception in 2005, the study has recruited over 10,000 volunteers with grandparents from the Hebrides, Orkney and Shetland archipelagos to participate in this research. The team conducts a comprehensive examination of participants’ genetic data by employing genome sequencing, comparing it against a benchmark list of medically significant genes compiled by the American College of Medical Genetics and Genomics. Many of these genes are associated with inherited cancer predisposition, cardiovascular risks, and metabolic diseases. So far, the Viking Genes team has identified 108 genetic variants linked to conditions such as breast cancer, ovarian cancer and heart dysfunction – findings that align with the known prevalence of these diseases in the Northern Isles.
One of the most transformative aspects of the Viking Genes study is being one of the first UK research projects to return actionable genetic findings – providing an ethical and logistical model for delivering potentially life-saving information back to participants. The team only contacts patients if their identified condition can be prevented or managed through NHS treatment. A striking example of the study’s success is the case of John Arthur, one of the 64 participants who received actionable findings. Upon being notified, John sought medical attention and was diagnosed with early-stage prostate cancer. Thanks to early detection, he received timely treatment, potentially saving his life. In his own words, “I would probably never have gone to the doctor about it until it was too late for anything to be done.” Beyond that, many other volunteers now collaborate closely with the research team to advocate for genetic screening as a proactive tool in disease prevention. Although recruitment for the study has closed, securing funding remains essential to continuing this vital work. Despite its potential to improve public health, this type of research often struggles to receive traditional academic funding, making donations crucial for its continuation.
The Viking Genes study highlights the critical role of genetic research in preventing early deaths and identifying carriers of harmful variants before a condition manifests. It also emphasises the indispensable contributions of volunteers, whose participation has helped advance science and medicine. The Viking Genes study stands as a testament to the power of genetic science in transforming lives and shaping the future of personalised medicine.
Photo by Ewan Harvey on Unsplash